Global Information
회사소개 | 문의 | 비교리스트

혈소판 및 혈장 시장 : 컴포넌트별, 애플리케이션별, 유통 채널별 - 지역 전망, 성장 가능성, 가격 동향, 경쟁 시장 점유율과 예측(2020-2026년)

Platelet and Plasma Market Size By Component, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026

리서치사 Global Market Insights Inc.
발행일 2020년 06월 상품 코드 945481
페이지 정보 영문 110 Pages
가격
US $ 5,150 ₩ 6,070,000 Unprintable PDF (Single User License)
US $ 7,150 ₩ 8,428,000 Printable PDF (Multi User License)
US $ 9,150 ₩ 10,786,000 Printable PDF (Enterprise User License)


혈소판 및 혈장 시장 : 컴포넌트별, 애플리케이션별, 유통 채널별 - 지역 전망, 성장 가능성, 가격 동향, 경쟁 시장 점유율과 예측(2020-2026년) Platelet and Plasma Market Size By Component, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026
발행일 : 2020년 06월 페이지 정보 : 영문 110 Pages

혈소판 및 혈장 시장은 전 세계에서 만성질환의 발생이 증가하고 있으므로 향후 수년간 상당한 성장을 보일 것으로 전망됩니다. 컴포넌트 부문에서 혈장 부문은 자가면역질환, 혈우병, 유전성 혈관부종 및 기타 감염증 등 희귀 만성질환에서 혈장 사용의 증가에 의해 예측 기간 중 약 2%의 CAGR을 보일 것으로 전망됩니다. 애플리케이션 부문에서 주술기 질환은 주요 침습적 수술에서 대량의 실혈을 수반함으로써 환자의 혈소판을 수혈로 보충할 필요가 있으므로 2019년에 약 15%의 시장 점유율을 구성했습니다. 유통 채널 부문에서 외래 수술 센터는 적정 요금으로 양질의 치료를 받을 수 있으므로 사람들의 관심이 증가함에 따라 예측 기간 중 약 2.5%의 CAGR을 보일 가능성이 있습니다. 지역별로는 라틴아메리카 지역이 혈우병, 자가면역 장애, 기타 감염증의 발생 비율이 높아지고 있으므로 2019년의 시장 규모는 4억 6,000만 달러를 웃돌았습니다.

세계의 혈소판 및 혈장 시장에 대해 조사분석했으며, 시장의 개요, 컴포넌트·애플리케이션·유통 채널·지역별 시장 동향, 시장 규모의 추이와 예측, 시장 촉진요인 및 저해요인 분석, 시장 전망, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

제1장 조사 방법

  • 조사 방법
  • 시장 정의
  • 예측 파라미터
  • 데이터 소스

제2장 개요

  • 혈소판 및 혈장 시장의 전방위적 개요
    • 비지니스 동향
    • 컴포넌트 동향
    • 애플리케이션 동향
    • 유통 채널 동향
    • 지역 동향

제3장 혈소판 및 혈장 업계 인사이트

  • 산업 세분화
  • 업계 상황
  • 산업 에코시스템
    • 밸류체인 분석
    • 유통 채널 분석
  • 업계에 대한 영향요인
    • 성장요인
    • 업계의 잠재적 리스크와 과제
  • 성장 가능성 분석
    • 컴포넌트별
    • 애플리케이션별
    • 유통 채널별
  • COVID-19 영향 분석
  • Porter의 산업 분석
  • PESTEL 분석

제4장 혈소판 및 혈장 시장 : 컴포넌트별

  • 주요 부문의 동향
  • 혈소판
    • 시장 규모 : 지역별(금액 기반)
  • 혈장

제5장 혈소판 및 혈장 시장 : 애플리케이션별

  • 주요 부문의 동향
  • 혈우병
    • 시장 규모 : 지역별(금액 기반)
  • 혈소판 감소증
  • 주술기 증상
  • 혈소판 기능 장애
  • 기타 혈소판 애플리케이션
  • 응고인자 결핍증
  • 혈전성 혈소판감소성자반병
  • 출혈
  • 간질환
  • 기타 혈장 애플리케이션

제6장 혈소판 및 혈장 시장 : 유통 채널별

  • 주요 부문의 동향
  • 병원
    • 시장 규모 : 지역별(금액 기반)
  • 외래 수술 센터
  • 기타

제7장 혈소판 및 혈장 시장 : 지역별

  • 시장 점유율 : 지역별
  • 북미
    • 시장 규모 : 국가별(금액 기반)
    • 시장 규모 : 컴포넌트별(금액 기반)
    • 시장 규모 : 애플리케이션별(금액 기반)
    • 시장 규모 : 유통 채널별(금액 기반)
    • 미국
    • 캐나다
  • 유럽
    • 시장 규모 : 국가별(금액 기반)
    • 시장 규모 : 컴포넌트별(금액 기반)
    • 시장 규모 : 애플리케이션별(금액 기반)
    • 시장 규모 : 유통 채널별(금액 기반)
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
  • 아시아태평양
    • 시장 규모 : 국가별(금액 기반)
    • 시장 규모 : 컴포넌트별(금액 기반)
    • 시장 규모 : 애플리케이션별(금액 기반)
    • 시장 규모 : 유통 채널별(금액 기반)
    • 일본
    • 중국
    • 인도
  • 라틴아메리카
    • 시장 규모 : 국가별(금액 기반)
    • 시장 규모 : 컴포넌트별(금액 기반)
    • 시장 규모 : 애플리케이션별(금액 기반)
    • 시장 규모 : 유통 채널별(금액 기반)
    • 브라질
    • 멕시코
  • 중동·아프리카
    • 시장 규모 : 국가별(금액 기반)
    • 시장 규모 : 컴포넌트별(금액 기반)
    • 시장 규모 : 애플리케이션별(금액 기반)
    • 시장 규모 : 유통 채널별(금액 기반)
    • 남아프리카공화국
    • 사우디아라비아

제8장 기업 개요

  • Strategy Dashboard
  • America's Blood Centers
  • American Red Cross
  • American Association of Blood Banks
  • Blood Centers of America
  • European Blood Alliance
  • Indian Red Cross
  • Italian Red Cross
  • Japanese Red Cross
  • South African Red Cross Society
  • OneBlood
KSA 20.07.16

Data Tables

  • TABLE 1 Platelet and plasma industry 360 degree synopsis, 2015 - 2026
  • TABLE 2 Global platelet and plasma market, 2015 - 2026 (USD Million)
  • TABLE 3 Global platelet and plasma market, by component, 2015 - 2026 (USD Million)
  • TABLE 4 Global platelet and plasma market, by application, 2015 - 2026 (USD Million)
  • TABLE 5 Global platelet and plasma market, by region, 2015 - 2026 (USD Million)
  • TABLE 6 Industry impact forces
  • TABLE 7 Platelets market, by region, 2015 - 2026 (USD Million)
  • TABLE 8 Plasma market, by region, 2015 - 2026 (USD Million)
  • TABLE 9 Hemophilia market, by region, 2015 - 2026 (USD Million)
  • TABLE 10 Thrombocytopenia market, by region, 2015 - 2026 (USD Million)
  • TABLE 11 Perioperative indications market, by region, 2015 - 2026 (USD Million)
  • TABLE 12 Platelet function disorders market, by region, 2015 - 2026 (USD Million)
  • TABLE 13 Other platelet applications market, by region, 2015 - 2026 (USD Million)
  • TABLE 14 Coagulation factor deficiencies market, by region, 2015 - 2026 (USD Million)
  • TABLE 15 Thrombotic thrombocytopenic purpura market, by region, 2015 - 2026 (USD Million)
  • TABLE 16 Hemorrhage market, by region, 2015 - 2026 (USD Million)
  • TABLE 17 Liver disease market, by region, 2015 - 2026 (USD Million)
  • TABLE 18 Other plasma applications market by region, 2015 - 2026 (USD Million)
  • TABLE 19 Hospitals market by region, 2015 - 2026 (USD Million)
  • TABLE 20 Ambulatory surgical centers market by region, 2015 - 2026 (USD Million)
  • TABLE 21 Others market by region, 2015 - 2026 (USD Million)
  • TABLE 22 North America platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 23 North America platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 24 North America platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 25 North America platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 26 U.S. platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 27 U.S. platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 28 U.S. platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 29 Canada platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 30 Canada platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 31 Canada platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 32 Europe platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 33 Europe platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 34 Europe platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 35 Europe platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 36 Germany platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 37 Germany platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 38 Germany platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 39 UK platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 40 UK platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 41 UK platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 42 France platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 43 France platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 44 France platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 45 Italy platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 46 Italy platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 47 Italy platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 48 Spain platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 49 Spain platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 50 Spain platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 51 Asia Pacific platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 52 Asia Pacific platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 53 Asia Pacific platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 54 Asia Pacific platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 55 Japan platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 56 Japan platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 57 Japan platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 58 China platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 59 China platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 60 China platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 61 India platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 62 India platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 63 India platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 64 Latin America platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 65 Latin America platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 66 Latin America platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 67 Latin America platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 68 Brazil platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 69 Brazil platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 70 Brazil platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 71 Mexico platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 72 Mexico platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 73 Mexico platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 74 MEA platelet and plasma market size, by country, 2015 - 2026 (USD Million)
  • TABLE 75 MEA platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 76 MEA platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 77 MEA platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 78 South Africa platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 79 South Africa platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 80 South Africa platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 81 Saudi Arabia platelet and plasma market size, by component, 2015 - 2026 (USD Million)
  • TABLE 82 Saudi Arabia platelet and plasma market size, by application, 2015 - 2026 (USD Million)
  • TABLE 83 Saudi Arabia platelet and plasma market size, by distribution channel, 2015 - 2026 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global platelet and plasma market, 2015 - 2026 (USD Million)
  • FIG. 3 Growth potential analysis, by component
  • FIG. 4 Growth potential analysis, by application
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 PESTEL Analysis
  • FIG. 8 Strategy dashboard

Title:
Platelet and Plasma Market Size By Component (Platelets, Plasma), By Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), By Distribution Channel (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast, 2020 - 2026.

The platelet and plasma market is set to record considerable growth in coming years due to the increasing occurrence of chronic diseases across the globe. In modern day medical therapies, patients can receive either a pint of complete blood or just specific components present within the blood that are essential to treat particular conditions. This treatment approach, known as a blood component treatment, enables several patients to receive more benefit from a single pint of the donated whole blood.

Blood contains several different components, which includes platelets, red blood cells, plasma, and white blood cells. Today, the demand for platelet and plasma donations is increasing tremendously as they can address particular conditions more effectively.

In platelet donations, platelets are collected from the blood of a donor and then the remaining blood and the components in it are returned back to the donor. These platelets allows blood to clot, and are commonly given to people suffering from leukemia, to people undergoing chemotherapy, and to babies suffering from severe infections.

Similarly, the liquid part of the blood, known as plasma, is collected from the donor with the remaining components of the blood being returned back to the donor. Plasma also effectively helps blood to form clots, and is commonly used to treat people suffering from liver conditions, severe bacterial infections within the blood and burns.

The overall platelet and plasma market is divided into segments based on component, application, distribution channel, and regional landscape.

By component, the market is divided into platelets, and plasma. Among these, the plasma segment is expected to record around 2% CAGR through the forecast timeframe due to the rising usage of plasma in rare chronic diseases such as autoimmune diseases, hemophilia, hereditary angioedema and other infectious diseases.

In terms of application, the market is divided into thrombocytopenia, hemophilia, platelet function disorders, perioperative Indications, coagulation factor deficiencies, other platelet applications, hemorrhage, thrombotic thrombocytopenic purpura, other plasma applications, and liver disease.

Among these, the perioperative indications held around 15% market share in 2019 due to the significant blood loss during major invasive surgeries that is compensated by transfusing platelets in the patients.

Based on distribution channel, the industry is classified into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers is likely to witness around 2.5% CAGR over the projected timeframe, due to the increasing preference of people towards ambulatory surgeries owing to the quality treatment at affordable prices.

Regionally, the LATAM market held a market value of over $460 million in 2019, owing to the growing incidence of hemophilia, autoimmune disorder, as well as other infectious diseases.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data Sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Platelet and plasma industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Component trends
    • 2.1.3. Application trends
    • 2.1.4. Distribution channel trends
    • 2.1.5. Regional trends

Chapter 3. Platelet and Plasma Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry ecosystem
    • 3.3.1. Value chain analysis
    • 3.3.2. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
      • 3.4.1.1. Higher number of blood transfusions in Europe
      • 3.4.1.2. Recent advances in therapeutic protein drug development
      • 3.4.1.3. Increasing prevalence of liver diseases in elderly population
      • 3.4.1.4. Exclusive use of plasma for treatment of rare diseases in Europe
      • 3.4.1.5. Fair reimbursement in developed countries
    • 3.4.2. Industry pitfalls & challenges
      • 3.4.2.1. Stringent regulatory policies
      • 3.4.2.2. Affordability issue in APAC and Latin America due to high costs
  • 3.5. Growth potential analysis
    • 3.5.1. By component
    • 3.5.2. By application
    • 3.5.3. By distribution channel
  • 3.6. COVID-19 impact analysis
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Platelet and Plasma Market, By Component

  • 4.1. Key segment trends
  • 4.2. Platelets
    • 4.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.3. Plasma
    • 4.3.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 5. Platelet and plasma Market, By Application

  • 5.1. Key segment trends
  • 5.2. Hemophilia
    • 5.2.1. Market size, by region, 2015-2026 (USD Million)
  • 5.3. Thrombocytopenia
    • 5.3.1. Market size, by region, 2015-2026 (USD Million)
  • 5.4. Perioperative indications
    • 5.4.1. Market size, by region, 2015-2026 (USD Million)
  • 5.5. Platelet function disorders
    • 5.5.1. Market size, by region, 2015-2026 (USD Million)
  • 5.6. Other platelet applications
    • 5.6.1. Market size, by region, 2015-2026 (USD Million)
  • 5.7. Coagulation factor deficiencies
    • 5.7.1. Market size, by region, 2015-2026 (USD Million)
  • 5.8. Thrombotic thrombocytopenic purpura
    • 5.8.1. Market size, by region, 2015-2026 (USD Million)
  • 5.9. Hemorrhage
    • 5.9.1. Market size, by region, 2015-2026 (USD Million)
  • 5.10. Liver disease
    • 5.10.1. Market size, by region, 2015-2026 (USD Million)
  • 5.11. Other plasma applications
    • 5.11.1. Market size, by region, 2015-2026 (USD Million)

Chapter 6. Platelet and Plasma Market, By Distribution Channel

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.3. Ambulatory surgical centers
    • 6.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.4. Others
    • 6.4.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 7. Platelet and plasma Market, By Region

  • 7.1. Platelet and plasma market share, by region, 2017 & 2024
  • 7.2. North America
    • 7.2.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.2.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.2.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.2.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.2.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.2.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.3.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.3.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.3.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.7.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.7.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.8.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.8.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.3.9.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.9.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.4.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.4.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.4.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.4.7.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.7.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.5.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.5.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.5.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.5.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.5.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.6.2. Market size, by component, 2015 - 2026 (USD Million)
    • 7.6.3. Market size, by application, 2015 - 2026 (USD Million)
    • 7.6.4. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.6.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.5.3. Market size, by distribution channel, 2015 - 2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by component, 2015 - 2026 (USD Million)
      • 7.6.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.6.3. Market size, by distribution channel, 2015 - 2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Strategy Dashboard
  • 8.2. America's Blood Centers
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. American Red Cross
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. American Association of Blood Banks
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Blood Centers of America
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. European Blood Alliance
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Indian Red Cross
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Italian Red Cross
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Japanese Red Cross
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. South African Red Cross Society
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. OneBlood
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
Back to Top
전화 문의
F A Q